Bio-Path Holdings, Inc.
BPTH
$0.14
-$0.005-3.45%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -38.65% | 13.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.34% | -13.30% | |||
| Operating Income | 0.34% | 13.30% | |||
| Income Before Tax | -30.17% | -13.16% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -30.17% | -13.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.17% | -13.16% | |||
| EBIT | 0.34% | 13.30% | |||
| EBITDA | 0.84% | 13.32% | |||
| EPS Basic | 8.99% | 39.54% | |||
| Normalized Basic EPS | 8.97% | 39.54% | |||
| EPS Diluted | 8.99% | 39.54% | |||
| Normalized Diluted EPS | 8.97% | 39.54% | |||
| Average Basic Shares Outstanding | 43.02% | 87.16% | |||
| Average Diluted Shares Outstanding | 43.02% | 87.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||